| Item Type | Name |
|
Academic Article
|
Differential expression of MMAC/PTEN in glioblastoma multiforme: relationship to localization and prognosis.
|
|
Academic Article
|
Patterns of expression of Rb and p16 in astrocytic gliomas, and correlation with survival.
|
|
Academic Article
|
PAX6 suppresses growth of human glioblastoma cells.
|
|
Academic Article
|
Identification of necrosis-associated genes in glioblastoma by cDNA microarray analysis.
|
|
Academic Article
|
Phosphorylated Pak1 level in the cytoplasm correlates with shorter survival time in patients with glioblastoma.
|
|
Academic Article
|
Glioblastoma resection.
|
|
Academic Article
|
A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival.
|
|
Academic Article
|
Survival prediction in patients with glioblastoma multiforme by human telomerase genetic variation.
|
|
Concept
|
Glioblastoma
|
|
Academic Article
|
Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma.
|
|
Academic Article
|
A phase II trial of high-dose bromodeoxyuridine with accelerated fractionation radiotherapy followed by procarbazine, lomustine, and vincristine for glioblastoma multiforme.
|
|
Academic Article
|
Combination chemotherapy with 13-cis-retinoic acid and celecoxib in the treatment of glioblastoma multiforme.
|
|
Academic Article
|
Phase II study of carboplatin and erlotinib (Tarceva, OSI-774) in patients with recurrent glioblastoma.
|
|
Academic Article
|
Prognostic significance of glutathione S-transferase pi expression and subcellular localization in human gliomas.
|
|
Academic Article
|
Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials.
|
|
Academic Article
|
Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme.
|
|
Academic Article
|
Statistical pattern analysis of gene expression profiles for glioblastoma tissues and cell lines.
|
|
Academic Article
|
Multifaceted end points in brain tumor clinical trials: cognitive deterioration precedes MRI progression.
|
|
Academic Article
|
Phase 2 study of BCNU and temozolomide for recurrent glioblastoma multiforme: North American Brain Tumor Consortium study.
|
|
Academic Article
|
Phase II trial of irinotecan and thalidomide in adults with recurrent glioblastoma multiforme.
|
|
Academic Article
|
Reactivation of insulin-like growth factor binding protein 2 expression in glioblastoma multiforme: a revelation by parallel gene expression profiling.
|
|
Academic Article
|
Cognitive function as a predictor of survival in patients with recurrent malignant glioma.
|
|
Academic Article
|
Response and progression in recurrent malignant glioma.
|
|
Academic Article
|
O6-benzylguanine suppression of O6-alkylguanine-DNA alkyltransferase in anaplastic gliomas.
|
|
Academic Article
|
13-cis-retinoic acid in the treatment of recurrent glioblastoma multiforme.
|
|
Academic Article
|
Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme.
|
|
Academic Article
|
A North American brain tumor consortium (NABTC 99-04) phase II trial of temozolomide plus thalidomide for recurrent glioblastoma multiforme.
|
|
Academic Article
|
Correlation between dynamic MRI and outcome in patients with malignant gliomas.
|
|
Academic Article
|
Phase II trial of temozolomide plus the matrix metalloproteinase inhibitor, marimastat, in recurrent and progressive glioblastoma multiforme.
|
|
Academic Article
|
Activation of polyamine catabolism by N1,N11-diethylnorspermine leads to cell death in glioblastoma.
|
|
Academic Article
|
EFEMP1 suppresses malignant glioma growth and exerts its action within the tumor extracellular compartment.
|
|
Academic Article
|
Implications of bevacizumab discontinuation in adults with recurrent glioblastoma.
|
|
Academic Article
|
Characterization of pseudoprogression in patients with glioblastoma: is histology the gold standard?
|
|
Academic Article
|
Characterization of pseudoprogression in patients with glioblastoma
|
|
Academic Article
|
A relative increase in circulating platelets following chemoradiation predicts for poor survival of patients with glioblastoma.
|
|
Academic Article
|
Phase 1 lead-in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastoma.
|